Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6b85b68ef371ec9c8ce0c97811ea032a |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-5158 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-53 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-572 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-4748 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-0011 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-193 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
filingDate |
2008-07-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1d3eb130c3869d5bb1ccde2c807a58af http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_502eac8600550ac2024a0550233d8b38 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9e603019e988042e81add1340d511f5f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c362f388e035f5cda9e1e955159d06b8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f978f2a74b66e4607c1c50c89ce26c99 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_35187d62ddc0a6b4b46d7c5e12d3979c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_45a61a7c49780804bff0f48f305d332f |
publicationDate |
2009-02-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
CA-2694771-A1 |
titleOfInvention |
Composition of tumour-associated peptides and related anti-cancer vaccine |
abstract |
The present invention relates to immunotherapeutic peptides and their use in immunotherapy, in particular the immunotherapy of cancer. The present invention discloses tumour-associated T-helper cell peptide epitopes, alone or in combination with other tumour-associated peptides that serve as active pharmaceutical ingredients of vaccine compositions which stimulate anti- tumour immune responses. In particular, the composition of the peptides of the present invention can be used in vaccine compositions for eliciting anti-tumour immune responses against colorectal cancer. |
priorityDate |
2007-07-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |